Uploaded April 2026 | Updated September 2026, 1 week ago
Bowen Li, PhD, University of Toronto, 2024 Oxford-Harrington Rare Disease Scholar, is developing a novel tRNA-based therapy delivered to the lungs to restore protein function in cystic fibrosis patients with rare mutations, offering hope where current treatments fall short. The Oxford-Harrington Rare Disease Centre is a transatlantic initiative dedicated to accelerating breakthrough treatments and cures for rare diseases. Learn more: OxfordHarrington.org.
Bowen Li, PhD, University of Toronto, 2024 Oxford-Harrington Rare Disease Scholar, is developing a novel tRNA-based therapy delivered to the lungs to restore protein function in cystic fibrosis patients with rare mutations, offering hope where current treatments fall short. The Oxford-Harrington Rare Disease Centre is a transatlantic initiative dedicated to accelerating breakthrough treatments and cures for rare diseases. Learn more: OxfordHarrington.org.
